Thursday, 29 April 2021, 1:46 pm
Health Navigator NZ has created new, plain language fact
sheets that provide easy to understand information about the
type 2 diabetes medicine Empagliflozin.
The fact
sheets have been developed in English, te reo Māori, Samoan
and Tongan languages, providing clear, accurate information
about Empagliflozin.
The project is part of Health
Navigator NZ’s ongoing commitment to helping improve
health literacy and reduce health inequity.
PHARMAC
recently funded Empagliflozin (Jardiance) and Empagliflozin
+ metformin (Jardiamet) specifically for Māori and
Pasifika. These groups are at a high risk of complications
from type 2 diabetes, such as kidney and heart problems.